The imaging metrics were further correlated with CSF biomarkers for AD, including Aβ, total tau (T-tau) and P-tau, as well as an extensive neuropsychological battery assessing memory, language, visuospatial and executive functions. The gene discussed is MAPT; the disease is Alzheimer disease.